(+)-4，5-Bis[hydroxy(diphenyl)methyl]-2，2-dimethyl-1，3-dioxolane – (93379-49-8)

(-)-Sparteine, 90-39-1, .beta.-Isosparteine, (?)-Lupinidine, 446-95-7, Sparteine non-stereo, SCHEMBL8913122, CHEMBL2010478, DTXSID00859156, SLRCCWJSBJZJBV-UHFFFAOYSA-N, 7, 14-Methano-2H, 6H-dipyrido[1, 2-a:1', 2'-e][1, 5]diazocine, dodecahydro-, [7S-(7.alpha., 7a.alpha., 14.alpha., 14a.alpha.)]-, 7, 14-Methano-2H, 6H-dipyrido[1, 2-a:1', 2'-e][1, 5]diazocine, dodecahydro-, [7S-(7.alpha., 7a.alpha., 14.alpha., 14a.beta.)]-, 7, 14-Methano-2H, 6H-dipyrido[1, 2-a:1', 2'-e][1, 5]diazocine, dodecahydro-, [7S-(7.alpha., 7a.beta., 14.alpha., 14a.beta.)]-, STK801664, AKOS000732373, AKOS022142453, NCGC00181124-01, AS-44372, NCI60_000942, NCI60_002092, SY045591, DB-051242, 7, 15-diazatetracyclo[7.7.1.0~2, 7~.0~10, 15~]heptadecane, Dodecahydro-7, 14-methanodipyrido[1, 2-a:1', 2'-e][1, 5]diazocine, (7R, 7aR, 14R, 14aS)-Dodecahydro-7, 14-methano-2H, 6H-dipyrido[1, 2-a:1 inverted exclamation mark, 2 inverted exclamation mark -e][1, 5]diazocine